0001615219-16-000143.txt : 20160325
0001615219-16-000143.hdr.sgml : 20160325
20160325143010
ACCESSION NUMBER: 0001615219-16-000143
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160322
FILED AS OF DATE: 20160325
DATE AS OF CHANGE: 20160325
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Flex Pharma, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 BOYLSTON STREET
STREET 2: 24TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617-874-1821
MAIL ADDRESS:
STREET 1: 800 BOYLSTON STREET
STREET 2: 24TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02199
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Westphal Christoph H
CENTRAL INDEX KEY: 0001291961
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 161529467
MAIL ADDRESS:
STREET 1: C/O ALNYLAM PHARMACEUTICALS, INC
STREET 2: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4/A
1
wf-form4a_145893059937882.xml
FORM 4/A
X0306
4/A
2016-03-22
2016-03-23
0
0001615219
Flex Pharma, Inc.
FLKS
0001291961
Westphal Christoph H
C/O FLEX PHARMA, INC.
800 BOYLSTON STREET
BOSTON
MA
02199
1
1
1
0
President and CEO
Common Stock
2016-03-22
4
P
0
23951
11.78
A
2910955
I
See notes
The Form 4 filed on March 23, 2016 reported the purchase of 23,951 shares on March 21, 2016. This Amendment is being filed to correct the date of purchase. The rest of the information disclosed in the original filing for this purchase, including the footnotes, remains the same.
/s/ Robert Hadfield, Attorney-in-Fact
2016-03-25